New Key Statistics Module, Z-Score and F-Score
OTCPK:INBP Key Ratios
| Market Cap $ M | 9.92 |
| Enterprise Value $ M | 9.21 |
| P/E(ttm) | 13.74 |
| PE Ratio without NRI | 13.74 |
| Forward PE Ratio | -- |
| Price/Book | 0.51 |
| Price/Sales | 0.20 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 51.00 |
| EPS (TTM) $ | 0.02 |
| Beneish M-Score | -2.46 |
| 10-y EBITDA Growth Rate % | -2.10 |
| 5-y EBITDA Growth Rate % | -22.10 |
| y-y EBITDA Growth Rate % | 85.00 |
| EV-to-EBIT | 11.59 |
| EV-to-EBITDA | 3.94 |
| PEG | -- |
| Shares Outstanding M | 30.10 |
| Net Margin (%) | 0.84 |
| Operating Margin % | 1.56 |
| Pre-tax Margin (%) | 1.60 |
| Quick Ratio | 1.18 |
| Current Ratio | 3.04 |
| ROA % (ttm) | 1.63 |
| ROE % (ttm) | 2.26 |
| ROIC % (ttm) | 2.18 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.80 |
INBP Number of Guru Trades
INBP Volume of Guru Trades
Gurus Latest Trades with OTCPK:INBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:INBP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Integrated Biopharma Inc Insider Transactions
No Available Data
News about OTCPK:INBP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers